JPRN-UMIN000012802已完成未知
Evaluation of the clinical efficacy of anagliptin in type 2 diabetic patients with diabetic nephropathy. - Evaluation of the clinical efficacy of anagliptin in type 2 diabetic patients with diabetic nephropathy.
Kanazawa Medical University Diabetology and Endocrinology0 个研究点目标入组 50 人开始时间: 2014年1月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patient have been treated with DPP-4 inhibitors within 12 weeks before the study. 2.Patient have been treated with insulins, rapid acting insulin secretagogues, or a high dose of SU (glimepiride > 2mg/day, gliclazide > 40mg/day, glibenclamide > 1.25mg/day). 3.Patient who have a history of allergy to anagliptin. 4.Patients who have severe ketosis, diabetic coma, diabetic pre-coma, or type 1 diabetes 5.Patients who have severe infection,
研究者
相似试验
招募中
4 期
Clinical efficacy of anagliptin administration in type 2 diabetic patientsType 2 DiabetesJPRN-UMIN000011071Kuwana East Medical Center Cardiology40
已完成
不适用
Study of the effect of Anagliptin administration on the activity of glucagon after test meal loadingPatients with type II diabetes mellitusJPRN-UMIN000021102Arc Cardiovascular Clinic20
已完成
不适用
ong-term efficacy of anagliptin in patients with type 2 diabetes mellitusType 2 Diabetes MellitusJPRN-UMIN000048203aka Kinen Clinic299
已完成
不适用
Evaluation of efficacy and safety of Alogliptin in type 2 diabetic patients with chronic kidney diseaseType 2 Diabetic Patients with chronic kidney DiseaseJPRN-UMIN000008133Department of Internal Medicine, Division of Nephrology, Juntendo University Faculty of Medicine50
已完成
不适用
The efficacy of anagliptin in patients with type 2 diabetes mellitusJPRN-UMIN000027103Juntendo University Urayasu Hospital30